The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Mesenchymal stem/stromal cells in cancer therapy
Open accessAbstract
The multipotent mesenchymal stem/stromal cells (MSCs), initially discovered from bone marrow in 1976, have been identified in nearly all tissues of human body now. The multipotency of MSCs allows them to give rise to osteocytes, chondrocytes, adipocytes, and other lineages. Moreover, armed with the immunomodulation capacity and tumor-homing property, MSCs are of special relevance for cell-based therapies in the treatment of cancer. However, hampered by lack of knowledge about the controversial roles that MSC plays in the crosstalk with tumors, limited progress has been made with regard to translational medicine. Therefore, in this review, we discuss the prospects of MSC-associated anticancer strategies in light of therapeutic mechanisms and signal transduction pathways. In addition, the clinical trials designed to appraise the efficacy and safety of MSC-based anticancer therapies will be assessed according to published data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The adaptability of MSCs, although beneficial in regenerative medicine, may elevate the risk of these cells unintentionally developing tumorigenic characteristics in the context of malignancy [300, 301].”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [300]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent meta-analysis of MSC therapies in oncology revealed that modified MSCs may develop tumorigenic properties under prolonged culture conditions, especially with extensive passaging or exposure to pro-inflammatory cytokines.”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [300]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies indicate that genetic modifications intended to enhance the regenerative potential of mesenchymal stem cells (MSCs), such as the overexpression of fibroblast growth factor-2 (FGF-2) or hepatocyte growth factor (HGF), may unintentionally promote tumor growth.”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [300]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent investigations have demonstrated that MSCs possess significant plasticity, enabling them to adapt dynamically to their microenvironment.”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [300]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Studies indicate that MSCs derived from MM patients possess genetic mutations that increase their susceptibility to malignant transformation.”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [300]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P. H., Ugarte, D. A. D., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,762
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Stöckl, S., Göttl, C., Grifka, J. K., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,670
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“The tumor homing property of MSCs Since the development of cancer shares multiple similarities with wound healing, tumors are also known as “wounds that do not heal” [109].”
BackgroundMatrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,277
Research works printed but not linked: 2
- Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi’s sarcoma. J Exp Med. 2006;203(5):1235–47. · DOI · Paper page
- Wang W, Zhong W, Yuan J, Yan C, Hu S, Tong Y, et al. Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma. Oncotarget. 2015;6(39):42276–89. · DOI
Cited by
Sorted by citations
Items 201–300 of 374
Hu, J., Wang, N., Jiang, Y., Li, Y., Qin, B., Wang, Z., & Gao, L. (2024) · Stem Cells · doi:10.1093/stmcls/sxae044 · Cited by 4
Rehman, A., Panda, S. K., Torsiello, M., Marigliano, M., Tufano, C. C., Nigam, A., Parveen, Z., Papaccio, G., & Noce, M. L. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae077 · Cited by 7
Zhang, Y., Xu, C., Huang, Y., Tan, D., Luo, W., Zhang, Y., & Tan, Y. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12513 · Cited by 4
Bioinspired micro‐ and nanostructured systems for cancer therapy
Yang, R., Zhang, B., Fei, X., Cong, S., Zhao, S., Zhou, T., & Shen, Y. (2024) · MedComm · doi:10.1002/mco2.70025 · Cited by 4
Iida, Y., & Harada, M. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009683 · Cited by 4
Nicotinamide adenine dinucleotide rejuvenates septic bone marrow mesenchymal stem cells
Xia, X., Zhou, K., An, L.-Y., Zhao, M., Tian, B.-L., Zhao, J., Zhou, Z., & Yin, T. (2025) · World Journal of Stem Cells · doi:10.4252/wjsc.v17.i2.96893 · Cited by 4
Lotfy, A., & Wang, H. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10474-1 · Cited by 4
Ecological niches for colorectal cancer stem cell survival and thrival
Che, J., & Yu, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1135364 · Cited by 4
FALCO, E. D., Bordin, A., Menna, C., Dhori, X., Picchio, V., Cozzolino, C., Marinis, E. D., Floris, E., Giorgiano, N. M., Rosa, P., et al. (2023) · Journal of Oncology · doi:10.1155/2023/1011063 · Cited by 4
Volarević, V., Harrell, C. R., Arsenijević, A., Djonov, V., & Volarević, A. (2025) · Cells · doi:10.3390/cells14130978 · Cited by 3
Liu, L., Cai, Y., Liu, D., Fang, R., Huang, H., Zou, M., Chen, B., Peng, J., & Hao, L. (2026) · Biomaterials Science · doi:10.1039/d5bm01061f · Cited by 4
Aouabdi, S., Nedjadi, T., Alsiary, R., Mouffouk, F., & Ansari, H. R. (2024) · Tissue Engineering Part A · doi:10.1089/ten.tea.2023.0333 · Cited by 3
Mesenchymal Stem Cells in Myelodysplastic Syndromes and Leukaemia
Eroz, I., Lazar, R. A., Vadakekolathu, J. N., Rutella, S., & El‐Jawhari, J. J. (2024) · Biomedicines · doi:10.3390/biomedicines12081677 · Cited by 4
Adipose MSCs response to breast cancer cell-derived factors in conditioned media and extracts
Sadeghian, F., Kazemi, F., Pirsadeghi, A., Asadi, F., Tashakori, M., & Yousefi‐Ahmadipour, A. (2024) · Cell and Tissue Banking · doi:10.1007/s10561-024-10156-x · Cited by 3
Li, H., Hu, F., Pan, X., Wang, Q., Liang, H., Lv, L., Li, J., Chang, Y., Xing, G., Xing, G., et al. (2025) · Small · doi:10.1002/smll.202505863 · Cited by 3
Yao, S., Cen, Y., Lou, G., & Liu, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115486 · Cited by 3
Ramirez, J. A., Jiménez, M. C., Ospina, V., Rivera, B., Susana Fiorentino, G., Barreto, A., & Múnera, L. M. R. (2024) · Histochemistry and Cell Biology · doi:10.1007/s00418-024-02265-1 · Cited by 3
Xiao, R., Chen, Y., Hu, Z., Tang, Q., Wang, P., Zhou, M., Wu, L., & Liang, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073635 · Cited by 4
Tumor Microenvironment: Multiway Role in Drug Resistance
Hurrah, I. M., Mintoo, M. J., Fatima, K., Kousar, R., Mohiuddin, T., Wani, A., & Khan, S. U. (2024) · Springer eBooks · doi:10.1007/978-981-97-1666-1_5 · Cited by 3
Yi, C. (2024) · American Journal of Translational Research · doi:10.62347/pkyu4876 · Cited by 3
Mesenchymal stem cell transplantation plays a role in relieving cancer pain
Zhang, W., & Chen, D. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1483716 · Cited by 3
Wang, Y., Pang, X., Li, R., Chen, J., Chen, W., Zhu, H., Long, T., Li, J., Zheng, L., Deng, Y., et al. (2025) · Research · doi:10.34133/research.0594 · Cited by 2
Kawulok, A., Borzdziłowska, P., Głowala‐Kosińska, M., Fidyk, W., Smagur, A., Łasut-Szyszka, B., Gdowicz‐Kłosok, A., Mitrus, I., Wilkiewicz, M., Chwieduk, A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136212 · Cited by 3
Harnessing cells to improve transport of nanomedicines
Bezze, A., Mattioda, C., Ciardelli, G., & Mattu, C. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114446 · Cited by 3
Progress in Utilizing Chitosan-Based Nanoparticles for Pulmonary Drug Administration
Mercan, G., & Selçuk, Z. V. (2024) · ODÜ Tıp Dergisi · doi:10.56941/odutip.1442818 · Cited by 2
Johor, A., Mahadiuzzaman, A. S. M., Alqusayer, A. A., Alkarim, S., & Opo, F. A. D. M. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1521809 · Cited by 2
AFM-based nano detection of the effects of umbilical cord mesenchymal stem cells on hepatoma cells
Fu, J., Dong, J., Deng, Q., Chen, Y., Ju, T., Luo, J., & Wang, Z. (2025) · Analytical Methods · doi:10.1039/d5ay00553a · Cited by 2
Liu, Y., Yin, R., Tian, Y., & Meng, X. (2025) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ade212 · Cited by 2
Yang, F., Zhu, Z., Shi, L., & Liu, X. (2025) · Biocell · doi:10.32604/biocell.2025.064982 · Cited by 2
Ma, W., Si, Y.-X., Zhang, Y., Gao, W., Dong, Y.-G., Li, Y.-Q., Xu, Z., Xi, Q., & Li, Z. (2025) · World Journal of Stem Cells · doi:10.4252/wjsc.v17.i7.105371 · Cited by 3
Qin, X., Chen, J., Zhang, H.-N., Du, L., Ma, Y., Li, Y., Yu, L., Wang, Y., Wu, L.-F., Yu, Z., et al. (2025) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v17.i9.109980 · Cited by 2
Li, J., Li, F., Zhang, M., Wu, Y., Wang, M., & Zhang, P. (2025) · Leukemia Research · doi:10.1016/j.leukres.2025.108122 · Cited by 2
Li, Z., Luo, P., Zhou, Z., Cao, J., & Zhang, W. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04768-7 · Cited by 2
Yang, L., Li, Y., Wang, T., Zhao, Z., Li, W., Lv, J., Chen, H., Qi, Z., Wang, X., Bao, W., et al. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1653964 · Cited by 2
Zhou, Y., Ding, D., Liu, F., & Han, F. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s570068 · Cited by 2
Li, X., Chen, Y., Cai, J., Huang, Y., Chen, X., Yu, M., Fu, L., Chai, B., Zhang, C., Zhang, Z., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1687424 · Cited by 2
Chen, Z., Wu, M., Wang, X., & Liang, W. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151033 · Cited by 2
Chen, X., Qu, Y. Q., Zhang, Y., Zhang, D. W., Yang, C., Wang, L., Zhang, H.-T., Liu, W., Law, B. Y. K., & Wong, V. K. W. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114985 · Cited by 2
Challenges for CAR-T cell therapy in multiple myeloma: overcoming the tumor microenvironment
Cui, J., An, G., & Qiu, L. (2023) · Hematology and Oncology Discovery · doi:10.15212/hod-2022-0008 · Cited by 2
Mo, Z., He, J., Li, M., Guo, R., & He, Q. (2024) · Pharmaceutical Fronts · doi:10.1055/s-0044-1786681 · Cited by 2
Wei, N., Chen, X., Liu, D., Bu, X., Wang, G., Sun, X., & Zhang, J. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00914b · Cited by 2
Extraembryonic mesoderm cells derived from human embryonic stem cells rely on Wnt pathway activation
Wang, S., Shi, G., Duan, K., Yin, Y., & Li, T. (2024) · Cell Proliferation · doi:10.1111/cpr.13761 · Cited by 2
Niebergall‐Roth, E., Dieter, K., Frank, M. H., & Kluth, M. A. (2024) · Journal of Dermatological Treatment · doi:10.1080/09546634.2024.2419931 · Cited by 3
MACC1 is a potential prognostic biomarker for cancer immunotherapy in lung adenocarcinoma
Pan, C., Zhou, Z., Cao, J., Zhang, L., Cheng, T., Li, H., Jiang, Z., Huang, D., Zeng, D., Luo, Y., et al. (2025) · Carcinogenesis · doi:10.1093/carcin/bgaf015 · Cited by 2
Zhang, J., Zhang, J., Kang, L., Wang, F., Hao, H., Jiao, M., Liang, X., & Liu, D. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500778 · Cited by 2
Radzikowska-Büchner, E., Radej, S., Niezabitowska, E., Sitarz, R., & Szewc, M. (2025) · Cancer Management and Research · doi:10.2147/cmar.s516593 · Cited by 2
Anderson-Crannage, M., Nyström, A., Hirani, R., Schaefer, E., Hochberg, B., Kann, R., Pan, J., Tian, M., Zhu, H.-W., Luo, W., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.08.038 · Cited by 2
Senescence in Aging, Within the Brain and Other Diseases: Mechanisms and Interventions
Chakrabarti, S. K., & Chattopadhyay, D. (2023) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2023.00018 · Cited by 1
Recent advances in patient‐derived tumor organoids for reconstructing TME of head and neck cancer
Chen, L., Chen, Y., Ge, L., Zhang, Q., & Meng, J. (2024) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.13532 · Cited by 2
Hermansyah, D., Syarifah, S., Muhar, A. M., & Putra, A. B. (2024) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s457548 · Cited by 2
Chen, B. (2024) · American Journal of Cancer Research · doi:10.62347/bofp2157 · Cited by 1
Potential Use of Human Mesenchymal Stem Cells (hMSCs) in Pancreatic Damage/Cancer
Eyüpoğlu, H. Ö., Eyüpoğlu, E., & Serakıncı, N. (2024) · OBM Genetics · doi:10.21926/obm.genet.2403252 · Cited by 1
Mesenchymal Stem Cells in Cancer Therapy
Baran, Z., Çetinkaya, M., & Baran, Y. (2024) · Advances in experimental medicine and biology · doi:10.1007/5584_2024_824 · Cited by 1
Kareem, R. A., Sameer, H. N., Yaseen, A., Athab, Z. H., Adil, M., & Ahmed, H. H. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113848 · Cited by 2
Wang, Y., Wang, Z., Gao, Y., Zheng, T., & Liu, T. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s496326 · Cited by 1
Al-Toub, M., Alhamid, A. S., Aldahmash, B. A., Rady, A. M., Harrath, A. H., El-Hashash, A. H. K., Ganesan, P., & Savarimuthu Ignacimuthu, S. J. (2025) · Archives of Medical Research · doi:10.1016/j.arcmed.2025.103212 · Cited by 1
Mavaei, M., Farokhi, S., Yousefi, M. H., Fakouri, A., Shadab, A., Abdolmohammadi, M. H., Fallahian, F., & Afkhami, H. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1533065 · Cited by 1
Mesenchymal stem cell therapy for breast cancer‑related secondary lymphedema (Review)
Han, S., Cai, J., Zhang, Y., & Lu, F. (2025) · Molecular and Clinical Oncology · doi:10.3892/mco.2025.2868 · Cited by 1
Wang, X., Pan, Z., Liu, N., Dai, X., Yang, Y. N., Zhang, C., & Xu, Y. (2025) · BioScience Trends · doi:10.5582/bst.2025.01120 · Cited by 1
Jantalika, T., Manochantr, S., Kheolamai, P., Tantikanlayaporn, D., Pinlaor, S., Saijuntha, W., Paraoan, L., & Tantrawatpan, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-16789-6 · Cited by 2
Assessing the Hematological Cancer Stem Cell Landscape to Improve Immunotherapy Clinical Decisions
Diamantoudis, S. C., Miliotou, Α. N., Galatou, E., Telliou, S., Sideris, K., Grigoriadis, N., & Vizirianakis, I. S. (2025) · Biocell · doi:10.32604/biocell.2025.067216 · Cited by 2
Alarcón-Apablaza, J., Salazar, L. A., Loren, P., Martínez, C., & Fuentes, R. (2025) · Biomedicines · doi:10.3390/biomedicines13112776 · Cited by 1
Non‑coding RNAs in epithelial‑mesenchymal transition of renal cell carcinoma (Review)
Liu, Z., Zhou, H., Shen, J., Qi, Y., Gong, X., & Zhang, C. L. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13761 · Cited by 2
Mojallal, S., & Safari, F. (2025) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-025-10289-w · Cited by 1
Comprehensive review and reflective evaluation of cell therapies for tuberculosis
Zhao, L., Zhang, Y., Liu, R., Ni, B., & Bi, L.-J. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00232-25 · Cited by 2
Vogiatzi, I., Lehmann, A., Chuang, L. I. U., Moreno-Lama, L., Kajiwara, Y., Kanaya, N., Zwaenepoel, O., Farid, A. S., Lee, U., Rossignoli, F., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106122 · Cited by 1
Rallis, K. S., Dionísio, L. M., Tarannum, M., Romee, R., & Cancelas, J. A. (2026) · Molecular Therapy Oncology · doi:10.1016/j.omton.2026.201155 · Cited by 1
Wang, H., Wen, Y., Mai, L., Li, X., Lin, Y., Xiao, Z., Li, Y., Zhang, Y., & Chen, B. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153648 · Cited by 1
Hao, J., Zakershahrak, M., Ly, P., Huang, X., Sun, K., Zhang, S., Özer, F., & Chen, C. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18030394 · Cited by 1
Cai, Y., Wang, J., Liu, Y., Zhu, X., Yuan, Z., Li, W., Che, D., & Cao, D. (2026) · Open Research (University of Surrey) · doi:10.1002/viw.20250203 · Cited by 1
Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types
Yang, X., Yin, Q., Li, K., Wang, J., Song, R., Zhou, H., Han, S., Zhang, L., Zeng, Y., Xu, D., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.07.015 · Cited by 1
Mesenchymal stem cells: A promising weapon for cancer therapy
Zhou, X., Zhang, W., Liu, Y., Zhang, L., & Li, Z. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95346-7.00001-4 · Cited by 1
Li, Y., Fan, Y., Xie, Y., Li, L., Li, J., Liu, J., Jin, Z., Xue, H., & Wang, Z. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04000-y · Cited by 1
An, D., Wang, Y., & Wang, X. (2024) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10386 · Cited by 1
Zhang, K., & Zhao, F. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002571 · Cited by 1
Han, P., Fan, Y., Liu, Q., & Zhou, J. (2022) · Disease Markers · doi:10.1155/2022/6703053
Cheng, F., Wang, Z., You, G., Liu, Y., He, J., & Yang, J. (2023) · Research Square · doi:10.21203/rs.3.rs-2535332/v1
Ren, Q., Chai, M., Chen, K., Yu-zhe, G., Yan, Z., Cao, N., & Yu, C. (2023) · Research Square · doi:10.21203/rs.3.rs-3187070/v1
Aouabdi, S., Nedjadi, T., Alsiary, R., Mouffouk, F., & Ansari, H. R. (2023) · Research Square · doi:10.21203/rs.3.rs-3554160/v1
Vicentini, L. D., Correia, M. P. A., Tavares, T. G., Souza, E. A. O., Trivilin, L. O., & Boeloni, J. N. (2023) · Encontro Latino Americano de Iniciação Científica, Encontro Latino Americano de Pós-Graduação, INIC Jr, INID e ENEXUN (INIC/EPG) · doi:10.18066/inic0227.23
Al-Toub, M., Alhamid, A. S., Aldahmash, B. A., Rady, A. M., & El-Hashash, A. H. K. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4675577
Qin, X., Chen, J., Du, L., Ma, Y., Li, Y., Lu, Y., Wang, Y., Wu, L.-F., Yu, Z., Hu, M., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3736389/v1
Circulating immune cells and multiple myeloma: A mendelian randomization studyPreprint
Zhang, Z., Muhetaer, G., Xiahou, Z., Han, J., & Song, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4013936/v1
Stem Cell Therapies for the Treatment of Radiation and Chemotherapy Side Effects
Deptuła, M., Zawrzykraj, M., Czerwiec, K., Skrzypski, M. T., & Pikuła, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00086-x
Mesenchymal Stem Cells and Sarcoma
Hatina, J., Kripnerová, M., Dejmek, J., Dolejšová, M., & Pešta, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00116-5
Anti-cancer effect of Mesenchymal StemPreprint
Khalil, C., Gemayel, J., Salameh, R., Haddad, L., Ghanem, H., Moutran, D., Akouch, K., Hachem, G. E., Rustom, M., Hanna, C., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5377602/v1
Ibrahim, R. B., Gabr, H. M., Atia, F. M., & Hussein, A. A. (2025) · Egyptian Academic Journal of Biological Sciences. B, Zoology · doi:10.21608/eajbsz.2025.404827
Wang, C., Meng, Y., & Zhu, Y.-P. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5132844
Liu, X., Bian, H., Zhou, T., & Zhao, C. (2025) · FASEB BioAdvances · doi:10.1096/fba.2024-00235
Zorzoli, A., Brignole, C., Cocco, C., Idili, F., Segalerba, D., Morandi, F., Gramignoli, R., Villa, C., Alfei, S., Zuccari, G., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5226723
Tang, L., Peng, Z., & Peng, F. (2025) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2025.101556
Zhang, Y., Shi, Y., Zang, H., Zhao, X., Fu, X., Qiu, S., Zhang, Y., Liu, Y., Wan, X., Li, Z., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.163135
Peng, F., Long, Y., Zheng, T., Leng, M.-H., & Deng, H. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05332-w
Current Progress in Mesenchymal Stromal Cell Therapies
Al‐Anazi, K. A. (2025) · Journal of Regenerative Medicine and Biology Research · doi:10.46889/jrmbr.2025.6202 · Cited by 1
Gnao, K., Roy, M.-È., Zgheib, A., Desjarlais, M., & Annabi, B. (2025) · Oncology Letters · doi:10.3892/ol.2025.15151
Stem Cell Therapy for Cancer Treatment
Shukla, A. K., Bali, S. D., Mahadik, V. A., Sahoo, R., & Kadoo, N. Y. (2025) · doi:10.1002/9781394313785.ch14
Tian, J., Lv, C., Xie, T., Sun, Q., Liu, C., Ma, W., Liu, C., Cheng, R., Yin, K., & Xu, Y. (2025) · Human Genomics · doi:10.1186/s40246-025-00788-9
Problems and prospects for studying cancers on models of induced pluripotent stem cells
Kokaev, R. I., Islaev, A. A.-K., Galamatova, K. A., Vakhaeva, K. M., Tabalaeva, S. G., Bubaeva, Z. K.-P., Dudagova, R. M., Tazbaeva, R. S., Shapiyanova, M. T., Kodzaeva, I. A., et al. (2025) · Perm Medical Journal · doi:10.17816/pmj42342-57
The Role of Extracellular Vesicles in Synovial Injuries of Athletic Joints
Yan, L., Song, Y., Hu, S., Jianming, G., & Tao, X. (2025) · Journal of Sports Medicine and Therapy · doi:10.29328/journal.jsmt.1001095
Placental mesenchymal stem cell-derived interleukin-6 promotes neuroblastoma progression
Liu, Y. (2025) · American Journal of Cancer Research · doi:10.62347/knyx4079
Metadata
- Authors
- Lan, T., Luo, M., & Wei, X.
- Affiliations
- Sichuan University (CN)
- Corresponding author
- Luo, Min
- Wei, Xiawei
- ORCID
- Venue
- Journal of Hematology & Oncology
- Published
- 2021-11-17
- Volume
- 14
- Issue
- 1
- Pages
- 195-195
- ISSN
- 1756-8722 (ISSN-L)
- PMC
- PMC8596342
- OpenAlex
- W3211554128
- Cited by
- 374
- References
- 205
- Citations by year
- 2026: 63 · 2025: 105 · 2024: 103 · 2023: 91 · 2022: 12
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Hematology & Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation Regional Innovation and Development (U19A2003)
- National Major Scientific and Technological Special Project for “Significant New Drugs Development” (2018ZX09733001)
- Excellent Youth Foundation of the Sichuan Scientific Committee Grant in China (2019JDJQ008)
- Development Program of China (2016YFA0201402)
- National Natural Science Foundation of China (31800773)
- Sichuan Science and Technology Program (2019YJ0063)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- mesenchymal stem cells, cancer therapy, cell therapy, immunomodulation, tumor homing, signaling pathways, clinical trials, translational medicine
- MeSH terms
- Translational Science, Biomedical, Animals, Humans, Neoplasms, Mesenchymal Stem Cell Transplantation, Immunomodulation, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
